Antimicrobial Resistance (AMR) is recognized by the CDC and WHO as one of the greatest threats to public health worldwide. AMR occurs when bacteria mutate over time and no longer respond to antibiotics, making infections challenging to treat and increasing the risk of disease spread, severe illness, and death.
Benefits of Chronetyx UTI Assay
We can detect bacteria in a higher number of symptomatic patients than with urine culture. PCR can also detect more polymicrobial infections compared to urine culture. Culture-based testing alone can miss up to 67% of UTI infections. With the rise in antimicrobial resistance, our qPCR testing can detect both the pathogens and associated antimicrobial resistance genes within 24 hours leading to the right treatment and best outcomes for the patients.
Accuracy Matters – PCR vs. Culture
When an accurate diagnosis matters, speed of pathogen identification and clinical actionability are key. Chronetyx’s qPCR testing detects what traditional culture misses, particularly the known organisms and pathogens that are especially difficult, if not impossible, to culture.
| Chronetyx UTI Assay | vs. | Traditional Culture |
|---|---|---|
| Specimen this morning – Results this afternoon | Turn-Around-Time | Results can take an average of 3-14 days |
| Our Pathogen and Antibiotic Resistance Gene detection technology is the most sensitive technology available anywhere | Sensitivity | Typically, only detects the primary pathogen |
| Our technology specifically targets and identifies each pathogen found in a patient specimen | Specificity | Traditional cultures often yield “mixed flora” Results with no specificity of pathogens |
| Our technology detects pathogens that traditional culture often misses | Detection | Some pathogens are unculturable, some require greater incubation times |
| Our technology is not affected by a patients’ antibiotics use | Antibiotics | Antibiotics use may inhibit the growth of cultures |
Chronetyx assist providers by detecting Pathogens and Antibiotic Resistant Genes within hours of receiving the patient’s specimen. Rapid molecular testing removes guesswork by clinicians, and helps patients receive an antibiotic that works – the first time.
Our UTI Technology
Chronetyx UTI pathogen assay incorporates the latest in qPCR technology to analyze your patient’s sample rapidly and reliably. We utilize our in-house informatically driven automated qPCR platform technology that removes the potential for human error and produces the highest specificity and sensitivity in the market. Our assay accurately detects and differentiates greater than 99% of the most relevant viral, bacterial, and fungal pathogens, and associated antibiotics resistance genes.
CYX – UTI Pathogen and Anitibiotic Resistance Gene Panel
We provide the most rapid, sensitive, and specific Urinary Tract Infection (UTI) pathogen detection and associated antibiotic resistance gene panel test available anywhere in the world.
Patients and clinicians know within 24hrs if the antibiotic they were prescribed is the right one.
- Same day or next morning Results – depends on when the specimen is received.
- qPCR detection technology is diagnostically the most specific and sensitive technology available to detect both pathogen and other genes that confer resistance to antibiotic therapy.
- 99% accuracy for sensitivity and specificity for all present pathogens and antibiotic resistance genes.
- Our UTI assay targets both Pathogen and antimicrobial resistance gene.
- Our UTI assay detects pathogens that traditional cultures often miss.
- Detailed antibiotic sensitivity leads to better antibiotic utilization and stewardship.
- Rapid actionable results in less than 24hrs informing clinicians and patients that they are on the right antibiotic treatment.
- Traditional lab culture techniques turn-around times can range from three days to more than a week to get a finalized pathology report.
- Less than 1% of microbes can be grown in the lab. Lab culture techniques often fail to grow and are prone to error.
- Cultures are prone to errors, especially complicated infections.
- Detailed drug sensitivity leads to more precise use of antibiotics.
Chronetyx offers the most specific, sensitive, and rapid informatically driven fully automated qPCR platform technology for Urinary Tract Infections (UTI) available anywhere in the world. We identify the selected pathogenic microbes within a sample with 99.99% accuracy. The qPCR results for the selected pathogens and reflexed antibiotic resistance biomarkers. We offer the most stringent antibiotic resistance biomarker panel in the industry.
Cyx Solid Tumor 505
Cyx Solid Tumor 505 enables rapid and actionable genomic insights for all patients
with advanced cancer. FDA-cleared and CE-IVD-marked comprehensive tumor
profiling affords every patient access to personalized treatment options.
Quantitative Polymerase Chain Reaction (qPCR)
Quantitative Polymerase Chain Reaction (qPCR) is a powerful, cost-effective, efficient, reliable, and rapid technology used in real-time to detect and quantify naturally occurring and mutated nucleic acids (DNA/RNA) present in a specimen. qPCR has widespread applications in clinical diagnostics.
Next-generation
Sequencing (NGS)
Next-Generation Sequencing (NGS) is a cutting-edge technology that is indispensable to providing the most accurate, complete, and tailored diagnostic information to clinicians for clinical care.